Else Nutrition cheers signing of FDA funding package

Executive Summary

• Else Nutrition Holdings Inc. announced that President Trump signed the U.S. government budget for fiscal year 2026, ending the government shutdown and including a pivotal Congressional directive (H. Rept. 112-172) that directs the FDA to streamline regulatory pathways for non-dairy, non-soy, plant-based infant formulas.
• The company secured this provision through its government affairs initiatives, marking a significant milestone that is expected to accelerate regulatory guidance and approval processes for its target product category.
• With the shutdown concluded and FDA operations resuming under "Operation Stork Speed," Else Nutrition is positioned to accelerate engagement with federal regulators to scale U.S. access to its plant-based formula solutions.

Key Details

• Legislative Action: The U.S. government budget for fiscal year 2026 was signed into law, officially ending the government shutdown.
• Regulatory Directive: The budget includes report language in H. Rept. 112-172 directing the FDA to establish clear approval pathways and provide formal regulatory guidance specifically for plant-based, non-soy, non-dairy infant formulas.
• Target Audience: The directive recognizes the needs of families with infants suffering from allergies, intolerances, sensitivities, or those with lifestyle/ethical preferences.
• Operational Impact: The company expects the FDA guidance process to begin "in earnest" now that FDA employees have returned to work following the shutdown.
• Product Pipeline: Else Nutrition’s pipeline includes an already-launched toddler nutrition line made from whole foods (almonds, buckwheat, and tapioca) with clean-label appeal, which is strategically suited for the U.S. infant formula market once regulatory conditions allow.
• Government Initiative: The update references "Operation Stork Speed," an initiative led by President Trump and Secretary Robert F. Kennedy aimed at bringing new infant formulas to American infants.

Notable Quotes

• "For too many parents, the absence of truly inclusive formula options has been a daily worry... Congress has sent a clear directive: U.S. regulatory policy will soon catch up to the reality that babies' nutritional needs and families' values are evolving." — Hamutal Yitzhak, Co-founder and CEO
• "Else has long maintained that every child deserves safe, effective and nutritionally complete baby formula options that reflect today's values and challenges. With this legislative accomplishment, we are entering the final phase of the U.S. policy transformation that will enable us to bring those options to market more rapidly and responsibly." — Hamutal Yitzhak